Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business GlobeNewswire November 11, 2025 Completes Evaluation of Strategic Alternatives for Tissue Health Plus Segment FORT WORTH, TX, Nov. 11, 2025 (GLOBE NEWSWIRE) — Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing […]

Alico, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Monday, November 24, 2025

Alico, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on Monday, November 24, 2025 GlobeNewswire November 11, 2025 FORT MYERS, Fla., Nov. 11, 2025 (GLOBE NEWSWIRE) — Alico, Inc. (“Alico” or the “Company”) (Nasdaq: ALCO) today announced that the Company will release financial results for the fourth quarter and full year ended

High Roller Reports Q3 2025 Results

High Roller Reports Q3 2025 Results GlobeNewswire November 11, 2025 â— Q3 2025 revenue of $6.3 million, revenue of approximately $20.0 million the nine months ended September 30, 2025, a slight increase YoY â— Company increased gross margins, lowered operating expenses, and positive Adjusted EBITDA of $622 thousand â— High Roller achieved its first ever

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025

Nasdaq Announces End-of-Month Open Short Interest Positions in Nasdaq Stocks as of Settlement Date October 31, 2025 GlobeNewswire November 11, 2025 NEW YORK, Nov. 11, 2025 (GLOBE NEWSWIRE) — At the end of the settlement date of October 31, 2025, short interest in 3,402 Nasdaq Global MarketSM securities totaled 14,079,841,205 shares compared with 13,834,913,159 shares

Iridex Reports Third Quarter 2025 Financial Results

Iridex Reports Third Quarter 2025 Financial Results GlobeNewswire November 11, 2025 MOUNTAIN VIEW, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and procedure probes for the treatment of glaucoma and retinal diseases, today reported financial results for the third quarter

Lifecore Biomedical to Participate in Upcoming Investor Conferences

Lifecore Biomedical to Participate in Upcoming Investor Conferences GlobeNewswire November 11, 2025 CHASKA, Minn, Nov. 11, 2025 (GLOBE NEWSWIRE) — Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today announced that the company will participate in two upcoming investor conferences. Details regarding Lifecore's participation are as follows: Jefferies

Concrete Pumping’s Brundage-Bone Subsidiary Expands International Presence with Acquisition of C.G.A. Concrete Pumping Ltd in the Republic of Ireland

Concrete Pumping's Brundage-Bone Subsidiary Expands International Presence with Acquisition of C.G.A. Concrete Pumping Ltd in the Republic of Ireland GlobeNewswire November 11, 2025 DENVER, Nov. 11, 2025 (GLOBE NEWSWIRE) — Concrete Pumping Holdings, Inc. (Nasdaq: BBCP) (the “Company” or “CPH”) wholly-owned subsidiary Brundage-Bone Concrete Pumping, Inc. (“Brundage-Bone”), a leading provider of concrete pumping services based

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)

Aardvark Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(C)(4) GlobeNewswire November 11, 2025 SAN DIEGO, Nov. 11, 2025 (GLOBE NEWSWIRE) — Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases, today announced that on November 10,

MannKind to Present at the Jefferies Global Healthcare Conference

MannKind to Present at the Jefferies Global Healthcare Conference GlobeNewswire November 11, 2025 DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) — MannKind Corporation (Nasdaq: MNKD) announced today that Michael Castagna, Chief Executive Officer, and Chris Prentiss, Chief Financial Officer, are scheduled to present and share updates during the Jefferies London Healthcare

Scroll to Top